Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Suzuki

Thoracic Surgery (Cardiothoracic Vascular Surgery) Savannah, GA Medical Doctor

NPI 1851373351 CMS profile 174298

11700 Mercy Blvd Bldg 1, Savannah, GA 31419

Open in the dashboard

General payments

$14,464

250 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mark Suzuki of Savannah, GA is reported in the CMS Open Payments database as having received $14,464 across 250 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,356 17
2024 General $827 14
2023 General $2,002 20
2022 General $3,641 60
2021 General $1,746 45
2020 General $1,766 47
2019 General $3,127 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Suzuki
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Mark Suzuki were reported at $1,356. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Mark Suzuki Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $3,127 $886 $178–$3,167 $163
2020 $1,766 $341 $108–$1,605 $114
2021 $1,746 $453 $125–$1,886 $132
2022 $3,641 $695 $180–$2,566 $149
2023 $2,002 $745 $205–$2,662 $160
2024 $827 $799 $214–$2,967 $164
2025 $1,356 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $5,131 58 payments
  2. Edwards Lifesciences Corporation $3,678 63 payments
  3. Abbott Laboratories $1,108 35 payments
  4. Abiomed $905 6 payments
  5. Medtronic, Inc. $764 11 payments
  6. Terumo Cardiovascular Systems Corporation $579 8 payments
  7. LivaNova USA, Inc. $286 3 payments
  8. Maquet Cardiovascular U.S. Sales, L.L.C. $232 5 payments
  9. Davol Inc. $165 2 payments
  10. Medtronic Vascular, Inc. $162 7 payments
  11. Other $1,454 52 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,187 238 payments
  2. Travel and Lodging $4,276 12 payments
Products named General payments · program years 2019–2025
  1. SYNERGY ABLATION SYSTEM $3,075 19 payments
  2. Edwards SAPIEN 3 Transcatheter Heart Valve $1,685 17 payments
  3. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $1,093 8 payments
  4. Impella $905 6 payments
  5. AtriCure cryoICE cryoSPHERE Cryoablation System $836 16 payments
  6. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $802 28 payments
  7. Sarns $542 5 payments
  8. ATRICURE ATRICLIP LAA EXCLUSION $509 9 payments
  9. ATRICLIP LAA EXCLUSION SYSTEM $418 13 payments
  10. Avalus $319 5 payments
  11. Other $5,596 160 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$58,796

Medicare's payments for the services billed

Medicare patients

48

Average age 72

Services billed

155

13 women, 35 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Diabetes 56%
Chronic kidney disease 52%
Arthritis 48%
Heart failure 40%
COPD 33%
Atrial fibrillation 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

250 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record